These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22086511)

  • 1. Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans.
    Prabaker KK; Tran TP; Pratummas T; Goetz MB; Graber CJ
    J Hosp Med; 2012 Feb; 7(2):91-7. PubMed ID: 22086511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
    Horey A; Mergenhagen KA; Mattappallil A
    Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
    Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.
    Kullar R; Davis SL; Taylor TN; Kaye KS; Rybak MJ
    Pharmacotherapy; 2012 Mar; 32(3):195-201. PubMed ID: 22392452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity.
    Rostas SE; Kubiak DW; Calderwood MS
    Clin Ther; 2014 Jul; 36(7):1098-101. PubMed ID: 24931573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.
    Pritchard L; Baker C; Leggett J; Sehdev P; Brown A; Bayley KB
    Am J Med; 2010 Dec; 123(12):1143-9. PubMed ID: 21183005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
    Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
    Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of an Antimicrobial Stewardship Program on Patient Safety in Veterans Prescribed Vancomycin.
    Fodero KE; Horey AL; Krajewski MP; Ruh CA; Sellick JA; Mergenhagen KA
    Clin Ther; 2016 Mar; 38(3):494-502. PubMed ID: 26831569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
    Matson KL; Shaffer CL; Beck GL; Simonsen KA
    Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring.
    Han HK; An H; Shin KH; Shin D; Lee SH; Kim JH; Cho SH; Kang HR; Jang IJ; Yu KS; Lim KS
    Ther Drug Monit; 2014 Oct; 36(5):606-11. PubMed ID: 24577126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.
    Hanrahan TP; Harlow G; Hutchinson J; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA
    Crit Care Med; 2014 Dec; 42(12):2527-36. PubMed ID: 25083977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
    Cies JJ; Shankar V
    Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of vancomycin-associated nephrotoxicity.
    Moh'd H; Kheir F; Kong L; Du P; Farag H; Mohamad A; Zurlo JJ
    South Med J; 2014 Jun; 107(6):383-8. PubMed ID: 24945176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Elevated Vancomycin Serum Trough Concentrations Achieved Within the First 7 Days of Therapy Associated With Acute Kidney Injury in Children?
    Knoderer CA; Nichols KR; Lyon KC; Veverka MM; Wilson AC
    J Pediatric Infect Dis Soc; 2014 Jun; 3(2):127-31. PubMed ID: 26625365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
    Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China.
    Dong MH; Wang JW; Wu Y; Chen BY; Yu M; Wen AD
    Int J Infect Dis; 2015 Aug; 37():125-8. PubMed ID: 26159843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin.
    Masuda N; Maiguma T; Komoto A; Haruki Y; Sugiyama T; Kondo S; Teshima D
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.